Gaetano R Barile from River Vale, NJ, age 59

Name / Title

Company / Classification

Phones & Addresses

Gaetano Barile
Medical Doctor, Principal

Gaetano M D Barile
Medical Doctor's Office

635 W 165 St, New York, NY 10032

Gaetano Raymond Barile

Barile, Dr. Gaetano E
Lasik · Ophthalmology

1 E 71 St, New York, NY 10021
(646)4220200

Gaetano Barile
Ophthalmology

Columbia Ophthalmology Consult
Business Consulting Services

880 3 Ave, New York, NY 10022

Gaetano Barile
Oculist

Columbia Ophthamology Consulta
Offices and Clinics of Medical Doctors, Nsk

635 W 165 St, New York, NY 10032

Medicine Doctors

Gaetano Barile

view source

Specialties:

Ophthalmologist
Retina & Vitreous Surgeon

Address:

635 West 165Th Street, New York, NY 10032
1 East 71St Street, New York, NY 10021

Education:

Medical School - Cornell University Medical College
Manhattan Eye, Ear, Throat Hosp (Residency)
Moorfields Eye Hospital, London (Fellowship)

Board certifications:

American Board of Ophthalmology

Dr. Gaetano Barile, New York NY - MD (Doctor of Medicine)

view source

Specialties:

Ophthalmology

Address:

MEETH Ophthalmology
210 E 64Th St, New York, NY 10065
(212)7027400 (Phone)

Certifications:

Ophthalmology, 2008

Awards:

Healthgrades Honor Roll

Languages:

English
Spanish

Hospitals:

MEETH Ophthalmology
210 E 64Th St, New York, NY 10065

NewYork-Presbyterian/Weill Cornell Medical Center
525 East 68Th Street, New York, NY 10065

Education:

Medical School
Joan Sanford I Weill Medical College Of Cornell University
Graduated: 1991
Medical School
New York Presbyterian Hospital
Graduated: 1992
Medical School
Manhattan Eet Hospital
Graduated: 1995
Medical School
Moorfields Eye Hospital
Graduated: 1997
Medical School
Roosevelt Hosp/Harkness Eye Institute
Graduated: 1997

Gaetano Raymond Barile, New York NY

view source

Specialties:

Ophthalmology

Work:

MEETH Ophthalmology
210 E 64Th St, New York, NY 10065

Gaetano Barile, New York NY

view source

Specialties:

Ophthalmologist

Address:

635 West 165Th Street, New York, NY 10032

Languages:

English

Hospital affiliations:

Lenox Hill Hospital

Resumes

Gaetano Barile

view source

Us Patents

Rage-Related Methods For Treating And Preventing Diabetic Retinopathy
view source
US Patent:

20080207499, Aug 28, 2008
Filed:

Jun 28, 2006
Appl. No.:

11/477274
Inventors:

Gaetano Barile - River Vale NJ, US
Ann Marie Schmidt - Franklin Lakes NJ, US
International Classification:

A61K 38/17
A61P 9/10
A61P 27/02
US Classification:

514 12
Abstract:

This invention provides a method for treating diabetic retinopathy in a subject afflicted therewith, comprising administering to the subject's eyes a therapeutically effective amount of soluble RAGE or a derivative thereof, thereby treating diabetic retinopathy in the subject. This invention further provides a method for inhibiting the onset of diabetic retinopathy in a subject afflicted therewith, comprising administering a prophylactically effective amount of soluble RAGE or a derivative thereof to the subject's eyes, thereby inhibiting the onset of diabetic retinopathy in the subject.

Methods For Treating And Preventing Diabetic Retinopathy
view source
US Patent:

20070098709, May 3, 2007
Filed:

Jun 28, 2006
Appl. No.:

11/477406
Inventors:

Gaetano Barile - River Vale NJ, US
Ann Schmidt - Franklin Lakes NJ, US
International Classification:

A61K 38/48
A61K 31/426
US Classification:

424094630, 514365000
Abstract:

This invention provides a method for treating diabetic retinopathy in a subject afflicted therewith, comprising administering to the subject's eyes a therapeutically effective amount of an agent that modulates the binding between AGE and RAGE in the subject's eyes, wherein the agent is not soluble RAGE or a derivative thereof, thereby treating diabetic retinopathy in the subject. This invention further provides a method for inhibiting the onset of diabetic retinopathy in a subject comprising administering to the subject's eyes a prophylactically effective amount of an agent that modulates the binding between AGE and RAGE in the subject's eyes, wherein the agent is not soluble RAGE or a derivative thereof, thereby inhibiting the onset of diabetic retinopathy.